Intas Pharma wins Global Excellence Award

Intas Pharma wins Global Excellence Award Intas Pharmaceuticals Ltd. is one of the fastest growing Indian Pharma companies in domestic market with a CAGR of 28% for last 4 years. INTAS reckons 16th in the domestic formulation market as per the ORG-IMS Report of March 2007, with its overall revenue base touching USD 188 Million for the Fiscal ending 2006-07 which is expected to grow more than double by the Financial Year 2009-10. Intas has carved a niche for itself, when it comes to quality manufacturing of innovative therapeutic medicines at affordable costs. With leading presence in UK and Europe, Intas is recognized for its global reach. Intas is the 2nd largest company in Neuropsychiatry and among the top-10 in Orthopedics, Gastroenterology and Urology. Intas has a distinct presence in Cardiology, Diabetology, Pain Management, Oncology and Biotechnology &leads the way in Animal Healthcare. Intas is currently ranked No. 5 in Indian Animal Healthcare market with dominance in Livestock market and significant presence in Pet segment. Intas Pharmaceuticals has won the Animal Pharm Excellence Awards for the unmatched services offered by the company in the area of Corporate Social Responsibility (CSR). Internationally acclaimed publication on World Animal Health and Nutrition- Animal Pharm, have instituted these awards to celebrate innovation and to reward excellence, in the animal health care sector. The Animal Pharm Industry Excellence Awards are the mark of Global distinction at highest level of professional acknowledgement within the Animal Health Industries today. Intas Corporate Social Responsibility is primarily aimed at giving the organization the opportunity to make a difference beyond the core business. Intas received an outstanding review for itself for developmental works like The Neomec Project Shiksha scholarships for students and Polivet Journal for Veterinarians , informed Mr. Vijay Teng of Intas. Elaborating further on the projects, he informed that, nearly 180 meritorious veterinary students, have been benefiting by way of scholarships under the Neomec Project Shiksha for the last four years, while Polivet with a free circulation of around 9000 copies, is meant to enhance the knowledge of the veterinarians, all over India. Polivet has been recognized and indexed by many national and international agencies including CAB. Internationally recognized names in the animal health care form the esteemed panel of 12 judges, who after going through the tedious process of looking into varied health care activities; have adjudged the winner of Animal Pharm Excellence Award in 12 different categories. The awards were presented at the beautiful Gibson Hall, London on 25th September, 2007 wherein more than 100 top Animal Healthcare companies were represented. To name a few besides Intas who battled for the Award were Janssen Animal Health, Pfizer, Genitrix, Eurovet, Heska, Merial, etc. For Intas, Mr. Teng added, the Award assumes much significance, as the company's animal health care division is still at its evolving stage and during this crucial period the company is being recognized for its philanthropic works. The Award would provide Intas an impetus, for all its ongoing animal healthcare development programmes, and moreover it will motivate different Pharma companies to take up such kind of social responsibility activities in the future, Mr. Teng concluded.

Intas Pharma wins Global Excellence Award

Intas Pharmaceuticals Ltd. is one of the fastest growing Indian Pharma companies in domestic market with a CAGR of 28% for last 4 years. INTAS reckons 16th in the domestic formulation market as per the ORG-IMS Report of March 2007, with its overall revenue base touching USD 188 Million for the Fiscal ending 2006-07 which is expected to grow more than double by the Financial Year 2009-10. Intas has carved a niche for itself, when it comes to quality manufacturing of innovative therapeutic medicines at affordable costs. With leading presence in UK and Europe, Intas is recognized for its global reach.

Intas is the 2nd largest company in Neuropsychiatry and among the top-10 in Orthopedics, Gastroenterology and Urology. Intas has a distinct presence in Cardiology, Diabetology, Pain Management, Oncology and Biotechnology &leads the way in Animal Healthcare. Intas is currently ranked No. 5 in Indian Animal Healthcare market with dominance in Livestock market and significant presence in Pet segment.

Intas Pharmaceuticals has won the Animal Pharm Excellence Awards for the unmatched services offered by the company in the area of Corporate Social Responsibility (CSR). Internationally acclaimed publication on World Animal Health and Nutrition- Animal Pharm, have instituted these awards to celebrate innovation and to reward excellence, in the animal health care sector. The Animal Pharm Industry Excellence Awards are the mark of Global distinction at highest level of professional acknowledgement within the Animal Health Industries today.

Intas Corporate Social Responsibility is primarily aimed at giving the organization the opportunity to make a difference beyond the core business. Intas received an outstanding review for itself for developmental works like The Neomec Project Shiksha scholarships for students and Polivet Journal for Veterinarians , informed Mr. Vijay Teng of Intas. Elaborating further on the projects, he informed that, nearly 180 meritorious veterinary students, have been benefiting by way of scholarships under the Neomec Project Shiksha for the last four years, while Polivet with a free circulation of around 9000 copies, is meant to enhance the knowledge of the veterinarians, all over India. Polivet has been recognized and indexed by many national and international agencies including CAB.

Internationally recognized names in the animal health care form the esteemed panel of 12 judges, who after going through the tedious process of looking into varied health care activities; have adjudged the winner of Animal Pharm Excellence Award in 12 different categories.

The awards were presented at the beautiful Gibson Hall, London on 25th September, 2007 wherein more than 100 top Animal Healthcare companies were represented. To name a few besides Intas who battled for the Award were Janssen Animal Health, Pfizer, Genitrix, Eurovet, Heska, Merial, etc.

For Intas, Mr. Teng added, the Award assumes much significance, as the company's animal health care division is still at its evolving stage and during this crucial period the company is being recognized for its philanthropic works.

The Award would provide Intas an impetus, for all its ongoing animal healthcare development programmes, and moreover it will motivate different Pharma companies to take up such kind of social responsibility activities in the future, Mr. Teng concluded.